Year |
Citation |
Score |
2024 |
Poulton JS, Lamba S, Free M, Xi G, McInnis E, Williams G, Kudlacek ST, Thieker D, Kuhlman B, Falk R. High-resolution epitope mapping of commercial antibodies to ANCA antigens by yeast surface display. Journal of Immunological Methods. 113654. PMID 38432292 DOI: 10.1016/j.jim.2024.113654 |
0.467 |
|
2022 |
Agosto-Burgos C, Wu EY, Iannone MA, Hu Y, Hogan SL, Henderson CD, Kennedy KB, Blazek L, Herrera CA, Munson D, Falk RJ, Ciavatta DJ, Free ME. The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis. Clinical & Translational Immunology. 11: e1428. PMID 36381498 DOI: 10.1002/cti2.1428 |
0.474 |
|
2022 |
Chen D, McInnis E, Wu E, Stember K, Hogan S, Hu Y, Henderson C, Blazek L, Mallal S, Karosiene E, Peters B, Sidney J, James E, Kwok W, Jennette JC, ... ... Free M, et al. Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity. Journal of the American Society of Nephrology : Jasn. PMID 35672132 DOI: 10.1681/ASN.2021081142 |
0.466 |
|
2022 |
Massicotte-Azarniouch D, Herrera CA, Jennette JC, Falk RJ, Free ME. Mechanisms of vascular damage in ANCA vasculitis. Seminars in Immunopathology. PMID 35254509 DOI: 10.1007/s00281-022-00920-0 |
0.471 |
|
2020 |
Jones BE, Herrera CA, Agosto-Burgos C, Starmer J, Bass WA, Poulton CJ, Blazek L, Henderson CD, Hu Y, Hogan SL, Hu P, Xiao H, Wu EY, Chen DP, Jennette JC, ... Free ME, et al. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation. Kidney International. PMID 32446935 DOI: 10.1016/J.Kint.2020.04.037 |
0.483 |
|
2019 |
Free ME, Stember KG, Hess JJ, McInnis EA, Lardinois O, Hogan SL, Hu Y, Mendoza C, Le AK, Guseman AJ, Pilkinton MA, Bortone DS, Cowens K, Sidney J, Karosiene E, et al. Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis. Journal of Autoimmunity. 102306. PMID 31383567 DOI: 10.1016/J.Jaut.2019.102306 |
0.557 |
|
2019 |
Hogan SL, Nachman PH, Poulton CJ, Hu Y, Blazek LN, Free ME, Jennette JC, Falk RJ. Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Kidney International Reports. 4: 551-560. PMID 30993230 DOI: 10.1016/J.Ekir.2019.01.004 |
0.482 |
|
2019 |
Stember K, McInnis E, Hogan S, Hu Y, Pilkinton M, Bortone D, Peters B, James E, Kwok W, Vincent B, Mallal S, Jennette C, Ciavatta D, Falk R, Free M. 191. CRITICAL MPO EPITOPES DRIVE THE CD4+ T CELL RESPONSE IN MPO-ANCA VASCULITIS Rheumatology. 58. DOI: 10.1093/Rheumatology/Kez061.005 |
0.483 |
|
2018 |
McCall AS, Bhave G, Pedchenko V, Hess J, Free M, Little DJ, Baker TP, Pendergraft WF, Falk RJ, Olson SW, Hudson BG. Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. Journal of the American Society of Nephrology : Jasn. PMID 30279272 DOI: 10.1681/Asn.2018050519 |
0.61 |
|
2016 |
Free ME, Falk RJ. The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis. Journal of the American Society of Nephrology : Jasn. PMID 27160405 DOI: 10.1681/Asn.2016030347 |
0.489 |
|
2015 |
McInnis EA, Badhwar AK, Muthigi A, Lardinois OM, Allred SC, Yang J, Free ME, Jennette JC, Preston GA, Falk RJ, Ciavatta DJ. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis. Journal of the American Society of Nephrology : Jasn. 26: 390-9. PMID 25060059 DOI: 10.1681/Asn.2013101092 |
0.487 |
|
2013 |
Free ME, Bunch DO, McGregor JA, Jones BE, Berg EA, Hogan SL, Hu Y, Preston GA, Jennette JC, Falk RJ, Su MA. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis and Rheumatism. 65: 1922-33. PMID 23553415 DOI: 10.1002/Art.37959 |
0.559 |
|
2013 |
Free ME, Ciavatta DJ, Falk RJ. L26. How antigens influence the disease: an immunologist point of view. Presse MéDicale (Paris, France : 1983). 42: 577-9. PMID 23454000 DOI: 10.1016/J.Lpm.2013.01.026 |
0.477 |
|
2013 |
Roth A, Ooi J, Hess J, Van Timmeren M, Berg E, Poulton C, Mcgregor J, Burkart M, Hogan S, Hu Y, Winnik W, Nachman P, Stegeman C, Niles J, Heeringa P, ... Free M, et al. ANCA epitope specificity determines pathogenicity, detectability and clinical predictive value La Presse MéDicale. 42: 664. DOI: 10.1016/J.Lpm.2013.02.033 |
0.601 |
|
2013 |
Free M, Bunch D, Mcgregor J, Poulton C, Jones B, Berg E, Hogan S, Hu Y, Preston G, Jennette C, Falk R, Su M. ANCA disease patients have defective Treg function exacerbated by expansion of a suppression-resistant effector population La Presse MéDicale. 42: 656. DOI: 10.1016/J.Lpm.2013.02.015 |
0.481 |
|
2010 |
Free ME, Falk RJ. IL-17A in experimental glomerulonephritis: where does it come from? Journal of the American Society of Nephrology : Jasn. 21: 885-6. PMID 20466743 DOI: 10.1681/Asn.2010040408 |
0.406 |
|
Show low-probability matches. |